NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | -100.0% | 14 | -100.0% | 0.00% | – |
| Q4 2019 | $144,000 | +1957.1% | 95,590 | +1853.2% | 0.00% | – |
| Q3 2019 | $7,000 | -97.3% | 4,894 | -97.7% | 0.00% | – |
| Q2 2019 | $261,000 | +770.0% | 215,900 | +1790.7% | 0.00% | – |
| Q1 2019 | $30,000 | -50.8% | 11,419 | -69.0% | 0.00% | – |
| Q4 2018 | $61,000 | -95.3% | 36,819 | -86.2% | 0.00% | – |
| Q3 2018 | $1,297,000 | +103.9% | 267,417 | +162.5% | 0.00% | – |
| Q2 2018 | $636,000 | +1451.2% | 101,862 | +1944.2% | 0.00% | – |
| Q1 2018 | $41,000 | -28.1% | 4,983 | -10.9% | 0.00% | – |
| Q4 2017 | $57,000 | -52.5% | 5,593 | -59.3% | 0.00% | – |
| Q3 2017 | $120,000 | +21.2% | 13,749 | +0.5% | 0.00% | – |
| Q1 2017 | $99,000 | +76.8% | 13,681 | +43.1% | 0.00% | – |
| Q4 2016 | $56,000 | – | 9,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,962,657 | $3,100,000 | 2.37% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $62,000 | 0.02% |
| SlateStone Wealth, LLC | 62,000 | $39,000 | 0.01% |
| Allred Capital Management, LLC | 24,995 | $15,000 | 0.01% |
| Bridge Advisory, LLC | 23,564 | $15,000 | 0.01% |
| Livingston Group Asset Management CO (operating as Southport Capital Management) | 24,000 | $15,000 | 0.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 320,993 | $201,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 229,500 | $143,000 | 0.00% |
| Virtu Financial LLC | 41,401 | $26,000 | 0.00% |
| TSFG, LLC | 200 | $1,000 | 0.00% |